Prebet, T., Fenaux, P., & Vey, N. (2016, October). Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: Validation of the North American MDS consortium scoring system. Haematologica.
Chicago Style (17th ed.) CitationPrebet, Thomas, Pierre Fenaux, and Norbert Vey. "Predicting Outcome of Patients with Myelodysplastic Syndromes After Failure of Azacitidine: Validation of the North American MDS Consortium Scoring System." Haematologica Oct. 2016.
MLA (9th ed.) CitationPrebet, Thomas, et al. "Predicting Outcome of Patients with Myelodysplastic Syndromes After Failure of Azacitidine: Validation of the North American MDS Consortium Scoring System." Haematologica, Oct. 2016.
Warning: These citations may not always be 100% accurate.
